Related Experiment Video
Updated: Jun 14, 2026
11:43
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Metabolomic imaging for human prostate cancer detection
Chin-Lee Wu1, Kate W Jordan, Eva M Ratai
1Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Science Translational Medicine
|April 8, 2010
Summary
Metabolomic imaging offers a new way to detect prostate cancer. This magnetic resonance imaging approach accurately maps cancer biomarkers, improving biopsy guidance and reducing false negatives.
Area of Science:
- Biomedical Imaging
- Oncology
- Metabolomics
Background:
- Current radiological methods struggle with accurate in vivo prostate cancer localization.
- Random biopsies in at-risk patients lead to high false-negative rates.
- Metabolomic imaging shows promise for mapping cancer-specific biomolecular profiles to guide biopsies.
Purpose of the Study:
- To evaluate the potential of metabolomic magnetic resonance imaging (MRI) for detecting prostate cancer.
- To assess the accuracy of a novel malignancy index derived from MRI data.
Main Methods:
- Utilized a 7-tesla human whole-body MRI scanner to evaluate five whole prostates from cancer patients.
- Acquired localized, multi-cross-sectional, multivoxel magnetic resonance spectra.
- Constructed a malignancy index based on prostate cancer metabolomic profiles from prior 14-tesla analyses.
Main Results:
- The calculated malignancy index showed a linear correlation with prostate cancer lesion size.
- The approach demonstrated 93% to 97% overall accuracy in detecting prostate cancer lesions.
- This metabolomic imaging technique shows potential for improved prostate cancer detection.
Conclusions:
- Metabolomic imaging using high-field MRI can accurately detect prostate cancer lesions.
- This method offers a promising tool to improve biopsy accuracy and clinical management of prostate cancer.
- Further clinical utility of this approach warrants investigation.
